Digvijay seeks CBI probe into MP PMT scam, illegal drug trials

Image
Press Trust of India Bhopal
Last Updated : Aug 01 2013 | 1:05 AM IST
Congress General Secretary Digvijay Singh today demanded probe by CBI into "illegal" clinical trials of drugs in Madhya Pradesh and the "scam" in the Pre-Medical Test conducted earlier this year by the state Professional Examination Board (MPPEB).
"We (Congress) are sure that neither state police nor Lokayukta would probe the pre-medical test scam or even the drug trials and hence we are seeking CBI probe into these cases," Digvijay told reporters here.
Indore police had busted the gang of impersonators involved in the PMT scam and arrested its alleged kingpin Jagdish Sagar recently.
Police also arrested two officials of the Professional Examination Board (PEB) responsible for conducting exams for professional and other courses in Madhya Pradesh after Sagar's arrest.
"A number of ineligible students have secured admission in MBBS course due to the scam. Despite the wrongdoings coming to the surface, the state government is bent on making new recruitments through the MPPEB," Digvijay alleged.
The demand for CBI investigation came close on the heels of Leader of Opposition Ajay Singh seeking similar inquiry, alleging that the scam was connected to the top echelons of power.
Digvijay alleged that at least 100 people lost their lives due to illegal clinical trials of drugs conducted at various hospitals in the state.
According to NGOs and some doctors, illegal and unethical clinical trials were conducted on poor persons including juveniles, tribals and Dalits who were used as "guinea pigs" for testing of drugs and vaccines produced by multinational corporations.
The supreme court had last year expressed concerns over such trials, saying it's "unfortunate" that humans were being treated as "guinea pigs".
"Clinical trials can not be conducted on anyone without informing his or her family members but this rule was flouted in Madhya Pradesh," Digvijay alleged.
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Aug 01 2013 | 1:05 AM IST

Next Story